Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for DYNTQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2025 0.529M
June 30, 2025 0.0684M
March 31, 2025 -0.5796M
December 31, 2024 0.3896M
September 30, 2024 -0.3061M
June 30, 2024 -0.3035M
March 31, 2024 0.3826M
December 31, 2023 0.0223M
September 30, 2023 1.734M
June 30, 2023 -0.0738M
March 31, 2023 -0.0779M
December 31, 2022 -0.0901M
September 30, 2022 -0.091M
June 30, 2022 -0.0896M
March 31, 2022 -0.0883M
December 31, 2021 -0.0869M
September 30, 2021 -0.0853M
June 30, 2021 -0.0862M
March 31, 2021 3.376M
December 31, 2020 -0.133M
September 30, 2020 -1.134M
June 30, 2020 0.2887M
March 31, 2020 1.431M
December 31, 2019 -0.749M
September 30, 2019 -1.708M
Date Value
June 30, 2019 1.167M
March 31, 2019 -0.4612M
December 31, 2018 -0.8932M
September 30, 2018 -1.355M
June 30, 2018 -0.3467M
March 31, 2018 -0.5379M
December 31, 2017 6.009M
September 30, 2017 4.849M
June 30, 2017 6.746M
March 31, 2017 2.519M
December 31, 2016 0.8508M
September 30, 2016 -0.0968M
June 30, 2016 -0.0972M
March 31, 2016 -0.8095M
December 31, 2015 -0.0578M
September 30, 2015 -1.264M
June 30, 2015 3.433M
March 31, 2015 0.2851M
December 31, 2014 0.2708M
September 30, 2014 -3.064M
June 30, 2014 -0.2323M
March 31, 2014 -0.0857M
December 31, 2013 -0.0209M
September 30, 2013 0.0402M
June 30, 2013 -0.4569M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Accuray, Inc. 3.624M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 2.236M
ResMed, Inc. -263.16M
Rockwell Medical, Inc. -0.683M

Cash from Financing (Quarterly) Related Metrics